<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04794907</url>
  </required_header>
  <id_info>
    <org_study_id>10-PLN-003</org_study_id>
    <nct_id>NCT04794907</nct_id>
  </id_info>
  <brief_title>Retinal Care Data Repository</brief_title>
  <official_title>Retinal Care Data Repository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Retinal Care Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Retinal Care Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Retinal Care Data Repository's primary objective is to make data available for Retinal&#xD;
      Care to develop algorithms that improve the care of people with retinal diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The initial focus is to develop algorithms that prevent, delay the progression, or improve&#xD;
      treatment of diabetic retinopathy (DR) and age-related macular degeneration (AMD). Examples&#xD;
      include but are not limited to: describing the incidence, prevalence, and severity&#xD;
      distribution of DR and AMD in the overall population and subgroups; diagnosing specified&#xD;
      severity thresholds for DR and AMD; predicting the development and progression of DR and AMD&#xD;
      for the overall population, subgroups, and individuals; and recommending tests and treatments&#xD;
      to prevent or delay the progression of DR and AMD for the overall population, subgroups, and&#xD;
      individuals.&#xD;
&#xD;
      Data will be collected retrospectively and prospectively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk Stratification</measure>
    <time_frame>Decade</time_frame>
    <description>Predict the participant's risk of developing specific severity levels of DR and AMD</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <condition>Age Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>DR</arm_group_label>
    <description>Patients with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AMD</arm_group_label>
    <description>Patients age 55 and older</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Patient data will be collected from eye exams, surveys and medical record review.</description>
    <arm_group_label>AMD</arm_group_label>
    <arm_group_label>DR</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The DR cohort includes any patient with diabetes. The AMD cohort includes patients 55 years&#xD;
        and older.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diabetes or age 65 years and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Stephen R Fransen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Retinal Care Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen R Fransen, MD</last_name>
    <phone>4052097531</phone>
    <email>stephen.fransen@retinalcare.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Landon R Grace, PhD</last_name>
    <phone>4053066474</phone>
    <email>landon.grace@retinalcare.com</email>
  </overall_contact_backup>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 9, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

